Please login to the form below

Not currently logged in
Email:
Password:

David Theil joins Noxilizer as chief financial officer

He also takes up the role of senior vice president

US-based biotech Noxilizer has appointed David Theil as its new chief financial officer and senior vice president.

Theil has over 25 years of experience in financial, administrative and operational management, specialising in start-up and middle market life sciences companies.

Before joining the biotechnology firm, Theil held various senior management positions at IGEN International, Speciality Pharmaceuticals and Supernus Pharmaceuticals.

He has also served as manager of emerging business markets group for Deloitte & Touche where he worked with clients in biotechnology, communications, healthcare and technology companies.

Lawrence Bruder, Noxilizer's president and chief executive officer, said: “David brings experience that is critical to Noxilizer at this stage of the company.

“He has worked in growing companies and understands the opportunities and challenges.”

28th January 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Synergy Vision

Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics